Effective on trade date October 2, 2017, and pending all relevant CFTC regulatory review periods, this Advisory Notice will supersede CME Group Market Regulation Advisory Notice RA1614-5 from November 16, 2016. It is being issued to update answers in the Frequently Asked Questions (”FAQ”) section of this Advisory Notice (specifically, FAQ numbers 11, 16, and 17) to streamline information regarding CME Group’s self-match prevention (“SMP”) functionality.
Click HERE for full advisory.